← Leaderboards
Stephanie Kaye Watkins
Loyola University Chicago
$724,587
Attributed
$724,587
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2012–14$250K$187.5K$125K$62.5K$0
'12
'13
'14
Funding mix
By agency
NIH$724,587 · 1
By mechanism
R00$724,587 · 1
Top collaborators
No co-investigators on record.
Most similar at Loyola University Chicago
Same institution · by research overlap
- Eugene D. Kwon$5,382,460
- Divaker None Choubey$3,390,589
- Lydia L Doncarlos$2,803,805
- Patrick J Stiff$4,477,135
- Richard I Fisher$10,193,946
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectAndrogen ReceptorAndrogensAnimalsAnticancer ResearchAwardBinding SitesBiochemicalBiopsyCancer TherapyCancer TypeCareerCd8b1 GeneCell Cycle RegulationCell PhysiologyCellsCessation Of LifeCollaborationsComplementComplexCytokineDefectDendritic CellsAdoptive Transfer
Grant awards (3)
Reversing Tolerogenicity of Tumor Associated Dendritic Cells to Enhance Anti-Tumo$241,529
R00 · FY2014 · CA · contact PI
Reversing Tolerogenicity of Tumor Associated Dendritic Cells to Enhance Anti-Tumo$234,059
R00 · FY2013 · CA · contact PI
Reversing Tolerogenicity of Tumor Associated Dendritic Cells to Enhance Anti-Tumo$248,999
R00 · FY2012 · CA · contact PI